Collaborations between the pharmaceutical industry and contract research organizations continue to represent an attractive alternative to internal drug discovery within a single organization. Selcia’s Director of Discovery Vicky Steadman’s Viewpoint article, published this week in ACS MedChemLett, covers many of the business models and strategies that are employed in industry-contract research organization collaborations. 

Full article here:  http://dx.doi.org/10.1021/acsmedchemlett.8b00236